Nutrition Status of Adults Treated With Pegvaliase
NCT03792451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2021-03-04
Summary
Conduct a cross-sectional analysis of the nutritional status of individuals with PKU treated with pegvaliase for one or more years or who have followed an unrestricted diet for 6 or more months while on pegvaliase treatment. We will evaluate laboratory markers of nutritional status, including markers of protein and micronutrient nutriture. In addition, a three-day food record and food frequency questionnaire will be obtained to assess protein intake and overall diet quality.
Conditions
- Phenylketonurias
Interventions
- DRUG
-
Pegvaliase
Treated with pegvaliase for one or more years or followed an unrestricted diet for 6 or more months while being treated with pegvaliase.
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Krista Viau, PhD, RD · Boston Children's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-17
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
NCT05356377 ·Status: COMPLETED
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
NCT05579548 ·Status: RECRUITING
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
NCT04404530 ·Status: RECRUITING
-
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
NCT05813678 ·Status: RECRUITING
-
Nutritional Status in Phenylketonuria
NCT03820804 ·Status: COMPLETED
-
Phenylketonuria and Hyperphenylalaninemia Nutrition Study
NCT01879995 ·Status: COMPLETED
-
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
NCT00225615 ·Status: COMPLETED ·Phase: PHASE3
-
Betaine and Peroxisome Biogenesis Disorders
NCT01838941 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
NCT01560286 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
NCT01889862 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
NCT00924703 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
NCT01819727 ·Status: COMPLETED ·Phase: PHASE3
-
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
NCT01924026 ·Status: COMPLETED
-
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
NCT00272792 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
NCT05166161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06628128 ·Status: RECRUITING ·Phase: PHASE3
-
GMP Drink for PKU Study
NCT02915510 ·Status: COMPLETED ·Phase: NA
-
Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
NCT00688844 ·Status: COMPLETED
-
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
NCT03614234 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
NCT00634660 ·Status: COMPLETED ·Phase: PHASE1
-
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 ·Status: COMPLETED
-
Study of a National Cohort of Adult Patients With Phenylketonuria
NCT01619722 ·Status: COMPLETED